Thanks for your constructive feedback. I understand their journey is different to DXB. I also noted that soarsentan is not FDA approved. What I try to mean was if DXB could be there where Travere today, there is a significant potential.
Also, one thing I want to mention without being rude, even the best if tthe best could get their DD wrong.
Ann: Dimerix Presents at ASX Small & Mid-Cap Conference, page-39
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
45.5¢ |
Change
0.055(13.8%) |
Mkt cap ! $250.1M | |||
| Open | High | Low | Value | Volume |
| 40.5¢ | 47.0¢ | 40.3¢ | $5.392M | 12.10M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 14351 | 45.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 46.0¢ | 28878 | 5 |
View Market Depth
| Last trade - 16.10pm 30/05/2024 (20 minute delay) ? |
|
|||||
|
Last
45.3¢ |
Change
0.055 ( 13.1 %) |
||||
| Open | High | Low | Volume | ||
| 40.5¢ | 47.0¢ | 40.0¢ | 7666660 | ||
| Last updated 15.59pm 30/05/2024 ? | |||||
| DXB (ASX) Chart |